Other studies have shown that the Slit2 gene is suppressed in SCLC patients via several mechanisms including hypermethylation, loss of heterozygosity (LOH), and inactivating mutations [8, 9]. This evidence concerns the gene SLIT2 and small cell lung carcinoma.